The World CB & CDx Series
Since 2010, the World CB & CDx Series has been at the centre of the biomarker and diagnostic community, gathering thought leaders and pioneers in the biomarker, CDx and precision medicine fields.
Providing a much-needed platform for candid conversations on how to define, adopt and implement a CDx strategy to ensure your drug candidates are regulatory compliant, achieve reimbursement and gain market share, the event series is dedicated to helping to bring the right drug, to the right patient, at the right time.
As pharma, biotech, diagnostic and technology providers strive to develop more safe and effective precision medicine products that better target patient responders, join our industry-leading meetings to discover and translate novel predictive biomarker signatures into clinically validated companion diagnostic assays for their precision medicine candidates.
Events in Series:
Harness Spatial Technologies to Power Immunotherapy Research & Clinical Trials
Navigate European Regulations to Accelerate Patient Access to Personalised Drugs
Uniting Large Pharma, Innovative Biotech & Leading Academics Dedicated to Accelerating Precision Medicine Therapies to Patients in Need
Successfully Navigate Regulations, Unveil Clear Routes to Commercialization & Optimize Test Selection to Accelerate Patient Access to Personalized Medicines for Improved Disease Outcomes in Oncology & Beyond
Develop Gold Standard Methodologies to Understand Disease in a New Dimension
Trailblazing Collaborations to Deliver Precision Medicine to All Patients Faster
Accelerating Patient Access to Early & Affordable Detection & Surveillance Tests